Back

Lung microenvironments harbor Mycobacterium tuberculosis phenotypes with distinct treatment responses

Walter, N. D.; Ernest, J. P.; Dide-Agossou, C.; Bauman, A. A.; Ramey, M. E.; Rossmassler, K.; Massoudi, L. M.; Pauly, S.; Al Mubarak, R.; Voskuil, M. I.; Kaya, F.; Sarathy, J. P.; Zimmerman, M. D.; Dartois, V.; Podell, B. K.; Savic, R. M.; Robertson, G. T.

2023-02-04 microbiology
10.1101/2023.02.03.527062 bioRxiv
Show abstract

Tuberculosis lung lesions are complex and harbor heterogeneous microenvironments that influence antibiotic effectiveness. Major strides have been made recently in understanding drug pharmacokinetics in pulmonary lesions, but the bacterial phenotypes that arise under these conditions and their contribution to drug tolerance is poorly understood. A pharmacodynamic marker called the RS ratio quantifies ongoing rRNA synthesis based on the abundance of newly-synthesized precursor rRNA relative to mature structural rRNA. Application of the RS ratio in the C3HeB/FeJ mouse model demonstrated that Mycobacterium tuberculosis populations residing in different tissue microenvironments are phenotypically distinct and respond differently to drug treatment with rifampin, isoniazid or bedaquiline. This work provides a foundational basis required to address how anatomic and pathologic microenvironmental niches may contribute to the long treatment duration and drug tolerance during treatment of human tuberculosis.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.